VERZENIO VISION

Serial Number 98227410
601

Registration Progress

Application Filed
Oct 17, 2023
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

VERZENIO VISION

Basic Information

Serial Number
98227410
Filing Date
October 17, 2023
Abandonment Date
November 6, 2023
Drawing Code
3000

Status Summary

Current Status
Inactive
Status Code
601
Status Date
Nov 7, 2023
Classes
005

Rights Holder

Eli Lilly and Company

03
Address
Lilly Corporate Center
Indianapolis, IN 46285

Ownership History

Eli Lilly and Company

Original Applicant
03
Indianapolis, IN

Legal Representation

Attorney
Bruce W. Longbottom

Application History

7 events
Date Code Type Description Documents
Nov 7, 2023 ABN1 O ABANDONMENT - EXPRESS MAILED Loading...
Nov 7, 2023 MAB1 O ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT Loading...
Nov 7, 2023 MAB1 E ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT Loading...
Nov 6, 2023 EXAR I TEAS EXPRESS ABANDONMENT RECEIVED Loading...
Oct 25, 2023 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Oct 24, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 20, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Design Mark
The mark consists of the stylized wording "VERZENIO VISION" and design. The design consists of a horizontal line before and after a triangular shield-like shape formed with lines that intertwine positioned above the letter "Z" in the term "VERZENIO" which appears in a large font. The term "VISION" appears in a small font and is centered below the term "VERZENIO" with a horizontal line before and after the term "VISION".
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005